Hims & Hers Expands into At-Home Lab Testing with Trybe Labs Acquisition

The telehealth company aims to enhance personalized healthcare with affordable, comprehensive blood tests targeting various health conditions.

Hims & Hers has acquired New Jersey-based Trybe Labs, enabling at-home blood draws and lab testing for its users.
The new service will provide tests for hormone levels, cardiac risk, cholesterol, liver function, thyroid function, and more, with results used to create personalized treatment plans.
The acquisition was funded through cash on hand, though the company has not disclosed the transaction's financial details.
Hims & Hers plans to use de-identified data from the tests to advance its AI initiatives, including its MedMatch tool for recommending personalized treatments.
The company’s stock surged over 18% following the announcement, despite facing significant short interest and a recent Morgan Stanley downgrade.